ABBOTT PARK, Ill., March 31, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non ...
Add Yahoo as a preferred source to see more of our stories on Google. NORTH CHICAGO, IL — As demand for COVID-19 testing skyrockets during the omicron surge, officials at Abbott Labs hope to soon be ...
Nearly four months after closing an Illinois facility that made rapid, at-home COVID-19 tests, Abbott Laboratories now plans to restart production there amid a surge in demand for the tests.
“ The BinaxNOW Self Test opens the door for Americans to buy an accurate and affordable test on their own terms, when and where they need it,” said Andrea F. Wainer, executive vice president of Abbott ...
Abbott’s ABT BinaxNOW COVID-19 Ag Self Test recently got FDA’s Emergency Use Authorization (EUA) clearance for over-the-counter, non-prescription and asymptomatic use. With this latest regulatory go ...
Nearly four months after closing a Gurnee facility that made rapid, at-home COVID-19 tests, Abbott Laboratories now plans to restart production there amid a surge in demand for the tests. Production ...
As more people get vaccinated and states begin to roll back some of the restrictions put in place due to the COVID-19 pandemic — schools, agencies and workplaces are working on a plan on how to safely ...
MEMPHIS, Tenn. — There is a limited quantity of COVID-19 rapid home tests as they are flying off the shelves. But some people aren't buying them to test themselves for COVID, instead, they are testing ...
The Abbott BinaxNOW, a rapid antigen test, identified 95 percent of people carrying high levels of the virus, researchers found. By Emily Anthes The Abbott BinaxNOW, a widely used at-home coronavirus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results